Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Circulating Tumor DNA Testing in Solid Tumors and Lymphoma: ASCO Guideline.

JCO oncology practice·2026

Same author

Rationale and study design for a randomized clinical trial of HOPE-Genomics, a web-based intervention to improve cancer patients' understanding of genomic testing results.

Contemporary clinical trials·2026

Same author

Bereaved Caregiver Perspectives on Quality of Care at the End of Life Among Adolescents and Young Adults with Cancer.

Journal of palliative medicine·2026

Same author

Randomized clinical trial of an Acceptance and Commitment Therapy telehealth intervention ('REVITALIZE') to reduce fatigue interference in women with advanced ovarian cancer on PARP inhibitors: study protocol.

BMC cancer·2026

Same author

A scalable new model of germline cancer genomic care delivery: Assessing psychological outcomes.

Genetics in medicine : official journal of the American College of Medical Genetics·2026

Same author

Ethical dilemmas in climate change and healthcare delivery: a cross-sectional survey of US patient perspectives.

BMC medicine·2026

Same journal

Biology Over Monotherapy: Mature Results From European Organisation For Research and Treatment of Cancer 22033-26033 Reaffirm Molecular Stratification, Not Treatment Sequence, Defines Prognosis in Low-Grade Glioma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Same journal

Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Same journal

Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU).

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Same journal

Efficacy and Tolerability of Zenocutuzumab in Advanced <i>NRG1</i> Fusion-Positive Cholangiocarcinoma: Results From the eNRGy Phase II Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Same journal

Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Same journal

Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.2.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 1, 2026

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Published on: August 18, 2023

Physicians' attitudes about multiplex tumor genomic testing.

Stacy W Gray¹, Katherine Hicks-Courant, Angel Cronin

¹Stacy W. Gray, Angel Cronin, Barrett J. Rollins, and Jane C. Weeks, Dana-Farber Cancer Institute; Stacy W. Gray, Barrett J. Rollins, and Jane C. Weeks, Harvard Medical School and Brigham and Women's Hospital, Boston; and Katherine Hicks-Courant, University of Massachusetts Medical School, Worcester, MA.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

|March 26, 2014

Summary

This summary is machine-generated.

Physicians have varied plans for using multiplex somatic genomic tests in cancer care. Enhanced genomic education and guidelines are needed due to low physician confidence in genomic knowledge.

More Related Videos

Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens

Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens

Published on: January 21, 2019

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

Related Experiment Videos

Last Updated: May 1, 2026

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Published on: August 18, 2023

Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens

Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens

Published on: January 21, 2019

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

Area of Science:

Oncology
Genomics
Medical Practice

Background:

Predictive multiplex somatic genomic tests identify targetable alterations in cancer genes.
Understanding physician adoption of these transformative tests is crucial for clinical integration.

Purpose of the Study:

To assess physicians' current use of somatic testing and their attitudes toward multiplex genomic testing.
To evaluate physicians' confidence in genomic knowledge and its impact on test utilization.

Main Methods:

A survey was administered to adult cancer physicians at a major cancer center before enterprise-wide multiplex testing.
The survey assessed current somatic testing practices, attitudes towards multiplex testing, and genomic confidence.

Main Results:

Physician confidence in genomic knowledge varied, with 22% reporting low confidence.
Anticipated use of multiplex testing ranged from infrequent (18%) to frequent (25%).
Higher genomic confidence correlated with increased likelihood of testing and using actionable results.

Conclusions:

Physician approaches to incorporating multiplex genomic tests differ significantly.
Low genomic confidence suggests a need for evidence-based guidelines and improved physician education for effective genomically guided cancer care.